Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) is -45.52% lower on its value in year-to-date trading and has touched a low of $0.72 and a high of $45.60 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The BDRX stock was last observed hovering at around $1.62 in the last trading session, with the day’s loss setting it -0.16%.
Currently trading at $1.46, the stock is 23.83% and 2.07% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.54 million and changing -9.88% at the moment leaves the stock -60.30% off its SMA200. BDRX registered -96.16% loss for a year compared to 6-month loss of -71.43%. The firm has a 50-day simple moving average (SMA 50) of $0.46 and a 200-day simple moving average (SMA200) of -$0.03.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 14.96% gain in the last 1 month and extending the period to 3 months gives it a -44.49%, and is 39.05% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 27.94% over the week and 11.05% over the month.
Profit margin for the company is -1533.60%. Distance from 52-week low is 102.98% and -96.80% from its 52-week high. The company has generated returns on investments over the last 12 months (-135.68%).
Biodexa Pharmaceuticals Plc ADR quarterly earnings per share for the current quarter are estimated at $0 with sales reaching $240k over the same period.
Biodexa Pharmaceuticals Plc ADR (BDRX) Top Institutional Holders
14 institutions hold shares in Biodexa Pharmaceuticals Plc ADR (BDRX), with institutional investors hold 37.57% of the company’s shares. Institutions hold 31.32% of the Float.
The top institutional shareholder in the company is Cubist Systematic Strategies, LLC with over 3325.0 shares valued at $228.0. The investor’s holdings represent 1.41% of the BDRX Shares outstanding. As of Jun 29, 2023, the second largest holder is Millennium Management Llc with 2554.0 shares valued at $175.0 to account for 1.08% of the shares outstanding. The other top investors are UBS Group AG which holds 1778.0 shares representing 0.75% and valued at over $121.0, while Two Sigma Securities, LLC holds 0.20% of the shares totaling 473.0 with a market value of $32.0.
